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Abstract
Portal hypertensive inflammation is associated with chronic liver diseases. The 
three successive and overlapping systemic inflammatory phenotypes, i.e., neuro-
genic, immune, and endocrine, which characterize the wound-healing response, are 
expressed by the portal venous system upon liver injury. The diverse functions of 
hepatic stellate cells in homeostasis and inflammation indicate the versatile nature 
of these mesenchymal-derived cells, which could adopt numerous phenotypes 
according to the interstitial microenvironmental characteristics. Consequently, 
these inflammatory phenotypes could represent the reexpression of two extra-
embryonic functional axis, i.e., coelomic-amniotic and trophoblastic-vitelline, 
whose coupling in the portal system would induce a gastrulation-related pheno-
type. Therefore, hepatic stellate cells and liver-specific mesenchymal cells could 
recapitulate and couple these abovementioned extra-embryonic phenotypes during 
portal hypertension. These hepatic cellular population, thanks to their potential 
ability to integrate and reexpress functions showing analogies to extra-embryonic 
functions, display characteristics of stem/progenitor cells. In this way, during the 
development of portal hypertension, hepatic stellate cells not only could reexpress 
extra-embryonic functions, but also could adapt themselves in order to induce a 
gastrulation-related process in the space of Disse. Hence, by understanding the 
ontogenic interactions between hepatic stellate cells and the host inflammatory 
response in portal hypertension, it is possible to design effective therapeutic and 
prophylactic strategies to avoid or reverse wound-like hypertensive response.
Keywords: liver fibrosis, extra-embryonic functions, inflammation, wound-healing, 
portal hypertension
1. Introduction
Portal hypertension is a frequent complication of chronic liver disease [1]. At 
the same time, cirrhosis represents the final stage of chronic liver disease due to any 
cause [2]. Cirrhosis can be defined as an advanced stage of fibrosis involving the 
formation of the regenerative nodule of the parenchyma surrounded and separated 
by fibrotic septa, a scenario also characterized by significant changes in hepatic 
angioarchitecture [3–5].
The cause-effect relationship existing between inflammation and fibrotic 
processes is so narrow that the term “inflammatory fibrosis” [6] appropriately 
describes multiple fibrotic diseases, including local conditions, such as wound 
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healing [7] and liver cirrhosis [5]. Therefore, the chronic activation of the wound-
healing response represents the driving force for progressive fibrosis, eventually 
leading to liver cirrhosis and hepatic failure [5].
2. The wound-healing response
Knowledge relating to wounding repair and healing comprises a significant 
fraction of the science of surgery and its specialties [8]. Wound healing is an 
obligatory sequence of events starting with inflammation due to a variety of 
stimuli [9]. In lower vertebrate tissues, regeneration can restore injured organs and 
even severe limbs or other body segments [10]. However, in higher vertebrates, tis-
sue repair consists of a fibroproliferative response that usually results in a fibrotic 
scar [10, 11]. Regenerating vertebrates, such as zebrafish and salamanders, offer 
a unique example where wounds are not only resolved without the formation of a 
fibrotic scar, but also the wound tissue executes tissue patterning equivalent to the 
original process of embryonic development to restore lost tissue [11, 12].
Scarring is a frequent consequence of full-thickness mammalian wound healing 
[10, 13]. However, the mid-gestation fetus is capable of regenerative healing with 
wound healing indistinguishable from surrounding skin [14, 15]. Current therapies 
to minimize scarring in postnatal wound have attempted to recapitulate singular 
aspects of the fetal regenerative phenotype and have met with varying degrees of 
clinical success [14].
Cutaneous wound repair is an integration of dynamic interactive processes involv-
ing soluble mediators, formed blood elements, extracellular matrix, and parenchymal 
cells [10]. These processes follow a specific time sequence which is classically grouped 
into three interrelated phases: inflammation, proliferation with tissue formation, and 
tissue remodeling [16, 17]. In brief, coagulation and inflammatory cells are crucial to 
the initial inflammatory phase. Neutrophils and macrophages enter the fibrin-rich 
zone. In addition to phagocyte pathogens and tissue debris, these cells secrete a mul-
titude of chemokines, cytokines, and growth factors. Granulation tissue—composed 
of macrophages, fibroblasts, and endothelial cells—is the hallmark of the prolifera-
tive phase. Reepithelization is essential for the reestablishment of tissue integrity 
[18]. During the remodeling phase, formation of granulation tissue ceases through 
apoptosis of the responsible cells. With maturation of the wound, the type III collagen 
deposited during the proliferative phase is slowly degraded and replaced with stron-
ger type I collagen. Furthermore, the wound undergoes a contractile response and 
reduces the surface area of the scar [19].
3. The systemic wound-healing phenotypes
From a general point-of-view, the wound-healing response could be considered 
as a systemic inflammatory response in the body, which appears to develop through 
the expression of three successive and overlapping phenotypes, the neurogenic, 
immune, and endocrine [20]. The above-mentioned phenotypes, which character-
ize the evolution of the systemic inflammatory response to the injury, are focused 
and integrated within the interstitial space of the injured tissue or organ [7, 21, 22].
3.1 The neurogenic inflammatory phenotype
The systemic inflammatory response begins with an immediate pathological neu-
romuscular response that includes sensitive impairments like stress sensation, pain, 
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analgesia, and motor alterations. In particular, these motor alterations are harm-
ful to the skeletal muscle (fight-to-flight and withdrawal reflexes), myocardium 
(tachycardia), and vascular smooth muscle (vasoconstriction and vasodilation), 
which induces systemic and local hemodynamic impairments, including blood flow 
redistribution and ischemia-reperfusion [21, 22]. A common and basic pathogenic 
mechanism of this complex neuromuscular response would be sudden hydroelectro-
lytic alterations [20–22]. Consequently, there is increasing evidence that the systemic 
inflammatory response is actually associated with abnormal ion transport [23].
The ischemia-reperfusion phenomenon, which causes oxidative and nitrosative 
stress, could be responsible for exudation and the progression of interstitial edema 
in the injured tissues or organs [21]. While edema is being produced, the lymphatic 
circulation is activated [20, 22]. Since the inflammatory interstitium is initially 
hypoxic and shows metabolic anaerobic acidosis, mainly due to the accumulation of 
acid by-products including lactate, the hypoxic and acid environment could repre-
sent an ideal stem cell niche [24].
In the early evolutionary period of the neurogenic stress response, the 
hypothalamic-pituitary-adrenocortical, sympathetic-adrenal-medullary, and 
renin-angiotensin-aldosterone axes, with the secretion of catecholamines, 
glucocorticoids, and mineralocorticoids in the circulation, are activated [25, 26]. 
Chromaffin vesicles in adrenal medullary chromaffin cells also store granins, 
which can function as prohormones giving rise to bioactive peptides, some with 
potent antimicrobial activity [27]. Consequently, these substances are selectively 
accumulated in the interstitial space of the tissues suffering from ischemia-
reperfusion because endothelial permeability is increased, especially in the 
post-capillary venules [7, 20–22] (Table 1 and Figure 1).
3.2 The immune inflammatory phenotype
The immune inflammatory phenotype corresponds to the intermediate phase of 
systemic wound-healing response to injury. In this phase, the tissue or organ which 
has previously suffered ischemia-reperfusion is infiltrated by inflammatory cells 
and even by bacteria [22]. This infiltration occurs in an edematous oxygen-poor 
environment [7, 21].
Today, the inflammatory bone marrow-related response is considered both a key 
and complementary arm of the stress response [7, 22]. The inflammatory activation 
of the bone marrow stem cell niche indicates the stimulation of the hematopoi-
etic stem cells (HSCs) and the mesenchymal stem cells (MSCs), which are both 
multipotent stem cells [28, 29]. HSCs are the progenitors of all blood and immune 
cells that infiltrate all the tissues and organs that have been previously primed by 
oxidative and nitrosative stress [22]. Inflammatory signaling molecules, including 
chemokines, interferons, tumor necrosis factor-alpha, and toll-like receptors appear 
to stimulate HSC proliferation in the short term [30]. In turn, interferon gamma 
mediates HSC stimulation in response to chronic inflammation [31].
This immune phenotype could be characterized by enzymatic stress related to 
intracellular digestion, i.e., autophagy [32], phagocytosis, and antigen presentation 
[21, 22]; and extracellular digestion, i.e., fermentation [20], all of which favor tissue 
tropism [7, 20]. In addition, macrophages and dendritic cells also take advantage 
of the lymphatic circulation activation. Macrophages migrate within the lymphatic 
circulation until reaching the lymph nodes where they activate lymphocytes [7, 33].
The cells that infiltrate the interstitium in the inflamed tissues and organs, thanks 
to the open microcirculatory system, acquire metabolic characteristics that transform 
them into tissues with great functional autonomy. Thus, leukocytes express adreno-
ceptors, catecholamines [34, 35], serotonin [36], pro-opiomelanocortin (POMC) 
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peptides [37], and cholinergic activity [38]. Perhaps, these are the reasons why the 
stress response axis can be retrieved by the immunocytes participating in the inflamed 
interstitium of tissues and organs, where the corticotrophin-releasing hormone (CRH), 
adrenocorticotrophin (ACTH)-like and biogenic amines are present [37].
MSCs are usually derived from bone marrow, but can also be isolated from 
adipose and other tissues [29]. MSCs act through complex interactions with the 
endogenous cells and tissues, and they may function in the multiple mechanisms of 
tissues [39]. MSCs in the wound bed contribute to the generation of a high-quality 
well-vascularized granulation tissue; they enhance reepithelialization of the wound 
and attenuate the formation of fibrotic scar tissue [39, 40]. Bone marrow-derived 
MSCs secrete molecules that inhibit the effector function of immune cells and are 
implicated in the resolution of inflammation [41, 42].
The neurogenic phenotype
Neuromuscular response
• Sensitive
 ○ Stress sensation, pain analgesia
• Motor
 ○ Skeletal muscle
 ○ Myocardium
 ○ Vascular smooth muscle
• Ischemia-reperfusion
• Oxidative and nitrosative stress
• Interstitial edema and storage of catecholamines, glucocorticoids, mineralocorticoid and granins
• Impairment of lymphatic pumping
• Increased lymphatic drainage
The immune phenotype
Inflammatory bone marrow-related response
• Hematopoietic stem cells
 ○ Leukocytes
• Mesenchymal stem cells
 ○ Resolution of the immune response
 ○ Enhance the regenerative potential of the tissues
Acute-phase reaction
• Positive acute-phase proteins
• Alteration in lipid metabolism
The endocrine phenotype
Proliferative inflammatory mesenchyma
• Granulation tissue
 ○ Angiogenesis
 ○ Fibrosis
• Reepithelization
Table 1. 
The systemic wound-healing inflammatory phenotypes.
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During the expression of the immune phenotype, the acute-phase reaction 
becomes more prominent and exhibits diverse pathophysiological changes, includ-
ing pyrexia, leukocytosis, and dramatic changes in the plasmatic concentrations 
of acute-phase proteins [43, 44]. Acute-phase proteins are circulating biomark-
ers of inflammation and are defined as either positive or negative, depending on 
whether they increase or decrease during the inflammatory response [43]. Positive 
acute-phase proteins are synthesized by hepatocytes in response to IL-6 as part of 
the innate immune response [45]. Positive acute-phase proteins include proteins 
of the coagulation-fibrinolysis system (fibrinogen, prothrombin, factor VIII, 
Von-Willebrand factor, complement factors plasminogen), protease inhibitors 
(alpha-1-antitrypsin, alpha-1-antichymotrypsin), transport proteins (ceruloplas-
min, hemopexin, haptoglobin), and lipid transport proteins (serum amyloid A and 
serum amyloid P) [43, 44]. However, C-reactive protein is the main human acute-
phase protein and one of the more sensitive markers of inflammation [44, 46].
Negative acute-phase proteins including albumin invade the interstitium of the 
injured tissues or organs through its plasmatic storage [21]. In turn, a pivotal func-
tion of the positive acute-phase proteins increases the availability of cellular free 
cholesterol. In particular, it has been suggested that acute-phase serum amyloid A is 
part of a systemic response to injury to recycle and reuse cholesterol from destroyed 
and damaged cells [47]. In this case, the recycling of cholesterol during serious 
injury could play an important role in survival [47]. In fact, the predominance 
of the lipid metabolism with accumulation of cholesterol in the inflamed tissue 
could be attributed to its role as a precursor molecule of many hormones, including 
Figure 1. 
The systemic wound-healing phenotypes. N: the neurogenic phenotype with sensitive and motor functions 
including ischemia-reperfusion and edema. A niche is created that can host stem cell-like cells. This interstitial 
niche accumulates molecules from the neuroendocrine stress response of the organism. I: the immune 
phenotype is associated with acute-phase response and an inflammatory bone marrow-related response, i.e., 
hematopoietic stem cells and mesenchymal stem cells. E: the endocrine phenotype. Formation of a new tissue 
that could execute a regenerative role or a reparative role through fibrosis. A: angiogenesis; AG: adrenal gland; 
BMA: bone marrow; CNS: central nervous system; DAMP: damage-associated molecular pattern; E: edema; 
ER: epithelial regeneration; EV: post-capillary vascular endothelium; F: fibrosis; GT: granulation tissue; L: 
lymphocyte; Le: leukocyte; Mo: macrophages; M: myofibroblast; MN: monocyte; MSC: mesenchymal stem cell; 
PAMP: pathogen-associated molecular pattern; PMN: polymorphonuclear neutrophil leukocyte; SC: stem cells.
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aldosterone, corticoids, progesterone, androgens, and estrogens [48] and even 
vitamin D [49] (Table 1 and Figure 1).
3.3 The endocrine inflammatory phenotype
It could be proposed that the expression of this inflammatory phenotype 
represents a metamorphosis through the creation of a pseudo-tissue made by a 
provisional parenchyma, with stem-like cells, and leukocytes, associated with 
a provisional stroma, i.e., coagulation and complement systems-related, which 
is finally transformed into a definitive tissue [50]. There is scattered evidence 
supporting the hypothesis that mononuclear phagocytes interact with cells with 
progenitor or “bona fide” stem cell properties, and that this interplay may contrib-
ute to repair and remodeling [51]. Even, it has been hypothesized that the immune 
system could create overriding signals that push the mesenchyme toward scarring 
rather than regeneration [52].
It has been proposed that the focus of the systemic phenotypes, neurogenic and 
immune, on the interstitial space of the injured tissue could be completed in two 
steps [7]. First, the upregulated neurogenic phenotype, characterized by systemic 
cardiovascular, hemodynamic, and hydroelectrolytic alterations, could favor the 
development of an interstitial niche with appropriate biochemical properties for 
the recruitment of cells with stem cell properties [7, 53]. In turn, the upregulated 
immune phenotype could mediate the inflammatory bone marrow response with 
an acute-phase reaction and a lipid metabolic switch linked to steroid synthesis [7]. 
Finally, the progressive polarization and integration of the functions that character-
ize both systemic inflammatory functions phenotypes, i.e., neurogenic and immune, 
in the injured tissue would condition the evolution of the tissue repair [7, 54].
The new tissue, a proliferative inflammatory mesenchyma, could execute a 
regenerative role or by default, repair through fibrosis [54, 55]. If so, several days 
after injury, a subset of wound fibroblasts can differentiate into myofibroblasts, 
which is responsible for repopulating the wounded area in parallel to angiogenesis, 
thus forming the granulation tissue [21]. Macrophages, fibroblasts, and blood 
vessels move into the wound space as a unit, suggesting an interdependence of these 
cells during the tissue repair [10, 51].
However, the dominating cell in this phase is the fibroblast, which fulfills 
different functions, such as the production of collagen and extracellular matrix 
substances, i.e., fibronectin, glycosaminoglycans, and proteoglycans [13]. Fibrosis 
is generally preceded by robust angiogenesis and vascular regression suggesting that 
the vascular apoptotic burden may be important to the fibrotic outcome [56, 57]. 
Recruited bone marrow mesenchymal cells could also transdifferentiate into epithe-
lial cells [58] (Figure 1).
Therefore, the wound-healing response could be viewed as a successive and 
overlapping of systemic phenotypes, i.e., neurogenic and immune, which are 
coupled in the wounded area in order of reconstructing the injured tissue by regen-
eration or, by default, repairing it by fibrosis.
4. Inflammatory phenotypes and recapitulated ontogeny
Inflammation could recapitulate ontogeny by reexpressing two hypothetical 
extra-embryonic axes, i.e., exocoelomic-amniotic and trophoblastic-yolk sac in the 
interstitial space of the injured tissue [7, 22, 54]. If so, the inflammatory response 
could represent the postnatal debut of ancestral biochemical mechanisms that were 
used for normal embryonic development [22].
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After fertilization, the first stage of embryogenesis is the zygote, which 
undergoes cleavage by mitosis. When the morula stage is reached, the embryo 
establishes polarity. The cells bind tightly to each other, forming a compact sphere 
or blastocyst, with two cell layers. The outermost layer becomes the trophoblast, 
giving rise to the placenta. The inner cells become the inner cell mass, giving rise 
to the embryo and the remaining structures, including the exocoelomic cavity, the 
amnion, yolk sac, and allantois [59]. The extra-embryonic coelom or exocoelomic 
cavity surrounds the blastocyst, which is composed of two structures, the amnion 
and the primary yolk sac. At the end of the fourth week of gestation, the develop-
ing exocoelomic cavity splits the extra-embryonic mesoderm into two layers, the 
somatic mesoderm, lining the trophoblast, and the splanchnic mesoderm, covering 
the secondary yolk sac and the embryo [60] (Figure 2).
The hypothetical recapitulation of these initial phases of the embryonic devel-
opment during the early inflammatory response would imply the expression of 
functions similar to the extra-embryonic exocoelomic-amniotic and trophoblastic-
yolk sac structures [22]. Accordingly, the exocoelomic-amniotic phenotype could 
be adopted by the inflamed interstitium that subsequently induces the accumulation 
of fluid with similar characteristics to coelomic and amniotic fluids in an environ-
ment with low pH and oxygen [60–62]. In essence, interstitial edema with high 
levels of proteins, in particular albumin, as well as electrolytes, metals, amino 
acids, antioxidants, cytokines, growth factors, and cholesterol-derived hormones 
would be produced in the inflammatory exudate [60–65]. In addition, the amnion 
is an embryonic functional axis with strong neural potential [66]. Amnion-derived 
multipotent progenitor cells secrete a unique combination of cytokines and growth 
factors, called the amnion-derived cellular cytokine solution, which establishes a 
connection between mesenchymal and epithelial cells during embryo development 
[67]. Furthermore, pluripotent stem cells within the amniotic fluid could be a new 
source for stem cell research [68] (Figure 2).
In turn, during trophoblast differentiation, trophoblast cells exhibit intense 
phagocytic activation leading to events as diverse as engulfment and destruction 
of extracellular material and the production of inflammatory mediators that may 
modulate both the immune response [69] and trophoblast invasiveness [70]. The 
wall of the secondary yolk sac in mammals is formed by an external mesothelial 
layer facing the exocoelomic cavity, a vascular mesenchyme and an endodermal 
layer facing the yolk sac cavity [60]. The formation of blood islands in the mes-
enchymal layer promotes the development of hematopoiesis and angiogenesis. 
Hemangioblasts found in these blood islands could generate blood cells through 
intermediate progenitors called hemogenic endothelial cells [71]. From the sixth 
week of gestation, the secondary yolk sac appears as a cystic structure covered 
by numerous superficial small vessels [60]. The mesothelial and endodermal 
layers have absorptive functions and are active in endocytosis/digestion [72]. In 
addition, the endodermal layer in the source of several proteins including acute-
phase proteins, such as prealbumin, albumin, transferrin, and α1-antitrypsin 
[73], as well as α-fetoprotein, which is produced by both the adult and fetal 
liver [60, 71]. A major function of the yolk sac is carbohydrate, protein, and 
lipid accumulation for embryo nutrition (vitellum) [74]. The yolk sac, therefore, 
provides lipids and lipid-soluble nutrients to embryos during the early phases of 
development [74].
It could be considered that the trophoblastic-yolk sac-related phenotype could 
favor the regulation of lipid metabolism genes [75], the hematopoietic-cell derived 
control with recruitment of immune cells and the induction of an angiogenic 
switch [71] to enable new tissue immunological tolerance during the inflamma-
tory response [22]. In addition, through the synthesis and release of acute-phase 
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proteins, this extra-embryonic phenotype could reduce oxidative, nitrosative, and 
enzymatic stress, activate the complement-coagulation system, regulate the lipid 
metabolism [74], and favor phagocytosis [69, 70, 72], a specific form of endocytosis 
primarily associated with nutrition in unicellular organisms and with innate and 
adaptive immunity in mammals [69] (Figure 2).
The molecular and cellular contribution made by the above-mentioned extra-
embryonic membranes, i.e., coelomic-amniotic and trophoblast-yolk sac to the 
intra-embryonic mesoderm, could be essential for embryo development and 
organogenesis [76]. Moreover, these primitive extra-embryonic structures can be 
internalized by the embryo at the early developmental stages [76]. Consequently, 
the hypothesized reexpression of the functions made by these extra-embryonic 
membranes during the postnatal life, when an inflammatory process is produced, 
could be a key process needed to repair the injured organism [7, 22, 54].
Both the coelomic-amniotic and trophoblast-yolk sac phenotypes reexpressed 
during the inflammatory response would therefore contribute to the formation of 
new tissue by regeneration and/or by scarring. Therefore, these two extra-embry-
onic phenotypes could act on the injured interstitium in a similar fashion as they act 
during embryonic development, using similar mechanisms [7, 22].
The hypothesized comparison between the coelomic-amniotic and trophoblastic-
yolk sac phenotypes with the neurogenic and immune inflammatory phenotypes, 
respectively, would explain that the interstitial integration of both pathological axes 
in the injured tissues and organs could finally induce a gastrulation-like process [54] 
(Figure 3). It could be accepted that the above-mentioned extra-embryonic pheno-
types are internalized during gastrulation to create the intra-embryonic mesoderm 
[76]. Gastrulation is the first major shape change of the developing embryo. In this 
development phase, the three embryogenic germ layers, i.e., ectoderm, mesoderm, 
and endoderm, are delineated [37]. Afterward, mesenchymal-epithelial transitions 
occur to create a secondary epithelium as part of somitogenesis. Then commitment 
and diversification of cells forming mesoendodermal structures are produced [77, 
78]. The concept that fibroblasts are simple residual embryonic mesenchymal cells 
explains the incorrect and often interchangeable substitution of the term fibroblast 
for mesenchymal cell [78]. The vast arrangement of the mesenchyma, in the extra- and 
intra-embryonic structures, suggests an important role of the mesenchyma in orches-
trating embryo development. In addition, mesenchymal stem cells are a versatile 
group of cells derived from mesodermal progenitors and can be found in several fetal 
and adult tissues [28–39].
Figure 2. 
The recapitulated extra-embryonic functions in the portal hypertensive inflammatory response. Inflammation 
could recapitulate ontogeny by reexpressing two hypothetical extra-embryonic axes: the exocoelomic-amniotic 
axis and the trophoblastic-yolk sac axis in the interstitial space of the injured tissue. The interstitial integration 
of both pathological axes into the injured tissues and organs could finally induce a gastrulation-like process, 
which contributes to develop a new tissue by regeneration and/or by scarring. A: amnion; EC: exocoelomic 
cavity; T: trophoblast; Y: yolk sac.
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5.  The portal hypertensive inflammatory response: an ontogenic 
recapitulation
The portal venous system includes all veins that carry blood from the abdominal 
part of the alimentary tract, spleen, pancreas, and gallbladder to the liver [79]. The 
fetal architecture of the afferent portal venous circulation of the liver is acquired 
between the fourth and sixth week. At the end of this process, the portal venous 
system is formed from several distinct segments of the previous extra-embryonic 
vitelline veins. The efferent venous vessels of the liver also derive from the extra-
embryonic vitelline veins [80].
The right and left paired vitelline veins transport blood from the yolk sac to 
the heart [80]. Hence, this type of circulation will be maintained and represented 
by the portal venous system; although, in this case, the blood transport is from 
the abdominal part of the alimentary tract, including the microbiome, spleen, 
pancreas, and gallbladder to the heart, but after passing through the liver [79]. 
Therefore, the portal venous system allows for the spatial distribution of different 
splanchnic functions and their coordinated integration that also is essential for the 
physiological functioning of the organism.
The existence of hyperpressure in the portal venous system induces the impair-
ment of the splanchnic functions that, in addition are aggravated by the associ-
ated progression of the liver disease [81]. It could be hypothesized that chronic 
hemodynamic, vascular, and metabolic changes in portal hypertension could have 
an inflammatory origin, most probably subsequent to splanchnic inflammation 
[81–83]. Since, it has been proposed that the inflammatory response could reca-
pitulate ontogeny by reexpressing the two hypothetical extra-embryonic axes, i.e., 
coelomic-amniotic and trophoblastic-yolk sac, in the interstitial space of the injured 
tissue [7, 22, 54], the splanchnic alterations related to portal hypertension could 
be also attributed to a recapitulation of the embryonic functions of the tissues and 
organs whose venous drainage is made for the portal system.
In this case, the splanchnic changes related to portal hypertension would rep-
resent the ontogenic recapitulation of the coelomic-amniotic-related (neurogenic 
inflammatory phenotype) and trophoblastic-yolk sac-related (immune inflam-
matory phenotype) functions. These functions would induce a gastrulation-like 
process (endocrine inflammatory phenotype), which would remodel it, since they 
are coupled into the interstitium of the splanchnic organs and tissues.
Figure 3. 
The reexpression of the two hypothetical extra-embryonic axes. The exocoelomic-amniotic axis and the 
trophoblastic-yolk sac axis in the interstitial splanchnic space; i.e., the gut-liver axis. The interstitial activation 
of these two extra-embryonic axes induce a gastrulation-like process, which causes portal fibrosis and steatosis 
in the liver while in the gastrointestinal tract an excessive angiogenic response is produced. BP: biliary 
proliferation; E: enterocyte; F: fibrosis; Fi: fibroblasts; G: goblet cell; KC: Kupffer cell; H: hepatocyte; HSC: 
hepatic stellate cell; IC: Ito cell; Le: leukocyte; Mo: macrophages; MF: myofibroblasts; SC: stem cells.
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6.  The reexpresion of the coelomic-amniotic-related phenotype in portal 
hypertension
Portal hypertension could evolve with the reexpression of the coelomic-amniotic 
phenotype, which begins with a pathological neuromuscular response that includes 
sensitive impairment, like unconscious stress sensation with autonomic dysfunc-
tion, and motor alterations including liver vasoconstriction (ischemia) and gut 
vasodilation (reperfusion) [1, 83]. It is noteworthy that although the mesenteric 
and the hepatic vascular beds share alterations in the same vasoactive pathways, 
they are not working in parallel [1]. Unlike the vasoconstriction in the intrahepatic 
vasculature, the alimentary tract vasculature undergoes a progressive vasodila-
tion. In turn, the splanchnic vasodilation produces systemic hypotension, vascular 
underfilling, stimulation of endogenous vasoactive systems, including the renin-
angiotensin-aldosterone system with save of Na+ and water, plasma volume expan-
sion, and increased cardiac index (hyperkinetic syndrome) [2, 79].
It is accepted that the hyperkinetic syndrome plays a key role in the pathogenesis 
of renal dysfunction and ascites in chronic liver disease [83]. Therefore, a basic 
pathogenic mechanism of this complex neurovascular response would be chronic 
hydroelectrolytic alterations [81].
The central nervous system has an initial and important influence in the evolu-
tion of portal hypertension. Chronic liver disease and portal hypertension can 
stimulate the hypothalamic-pituitary-adrenal axis and produce chronic secondary 
autonomic dysfunction [84] associated with a decreased response to vasoconstric-
tors, which may be caused by an increased concentration of vasodilators, including 
vasodilating peptides [85]. Chronic secondary autonomic dysfunction produces 
orthostatic hypotension, fatigue, gastrointestinal mobility disorders, with delayed 
gastric emptying, and prolonged transit times [84]. In addition, the central nervous 
system can influence immune function by stimulating the hypothalamic-pituitary-
adrenal axis. It can also activate specific pathways within the sympathetic nervous 
system, which mainly damps down the immune phenotype triggered by the inflam-
matory splanchnic response [86].
The later evolution of the portal hypertensive syndrome is possibly determined 
by increased endothelial permeability in the gut-liver axis, which is secondary to a 
complex neurovascular response, that it also produces interstitial edema [81]. The 
increased hydrostatic pressure should preferentially drive fluid into the lymphatics, 
thus increasing mesenteric lymph flow [87, 88] and resulting in dilation of cistern 
chili [89]. It is accepted that when the high-output state of the mesenteric lymph 
circulation is overwhelmed, excess lymph is collected in the peritoneal cavity 
leading to ascites [87] and in 0.5–1% of cirrhotic patients even chylous ascites [90]. 
It has been proposed that decompensation related to severe hepatic insufficiency 
would induce an acute-on-chronic inflammatory response [81]. In this case, the 
splanchnic interstitium, the mesentery lymph, and the peritoneal mesothelium seem 
to create an inflammatory axis that produces ascites [91, 92].
Ascitic fluid formation is a not well-known pathogenic mechanism. However, 
ascitic fluid is a bioactive medium containing electrolytes, with high levels of 
sodium and proteins including albumin and enzymes, as well as cells including 
leukocytes [93]. Some of these characteristics make it similar to another bioac-
tive medium, the amniotic fluid [94, 95]. Amniotic fluid, the protecting liquid 
contained in the amnion cavity, is an essential component for fetal development 
and maturation during pregnancy [95–97]. The hypothetical comparison of 
amniotic and ascitic fluid characteristics would make it worthwhile to reapproach 
the role of peritoneal mesothelial cells in the etiopathogeny of ascites in the portal 
hypertensive syndrome [81]. The functional comparison of amniotic and ascitic 
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fluids would imply that in the decompensated portal hypertensive syndrome, the 
abdominal mesothelium acquires properties of the amniotic membrane or amnion. 
This hypothesis would imply several suggestions. For example, the intestine and, 
by extension, the liver, could not benefit from the supposed trophic properties of 
the ascitic fluid, given that peritoneal cavity-gastrointestinal tract pathway does 
not exist [91, 92]. In this way, the ascitic fluid could have therapeutic actions if it is 
administered by the enteral route in the cirrhotic patients [91, 92].
The interstitial edema in the gut-liver axis could be considered as the space 
where the battle of inflammation develops. In particular, during the intestinal 
inflammatory response secondary to portal hypertension the interstitial space 
increases in size as a consequence of successive infiltration suffered by plasmatic 
molecules, blood cells, and bacteria. The impairment of the lymph pumping and 
lymphangiectasia also collaborate in producing splanchnic edema [98, 99]. There 
is increased intestinal epithelial permeability associated with the endothelial 
post-capillary permeability in patients with chronic liver disease [100]. Findings of 
increased endotoxin and bacterial DNA in blood in patients with cirrhosis support 
the relevance of the increased intestinal epithelial permeability observed in these 
patients with portal hypertension [99, 100].
Liver and biliary tract diseases are common extra-intestinal manifestations for 
inflammatory bowel diseases, including gut microbiota alterations [101–105]. This 
is why the etiopathogenic participation of the intestinal inflammatory response 
cannot be excluded from the pathology produced in the hepatic parenchyma in 
the cases of portal hypertension. In particular, this pathophysiological mechanism 
occurs when portal hypertension leads to increased permeability of the sinusoidal 
endothelium that, in turn, causes edema in the interstitial space of Disse [106]. 
It is evident that the space of Disse has a connection to the interstitial space of 
the portal tract or space of Mall [98]. Therefore, it is likely that fluid filtered 
out of the inflamed sinusoids into the space of Disse flows through the channel 
traversing the limiting plate to reach the interstitial space of the portal tracts [98]. 
Interestingly enough, it was found that superphysiological or pathological levels 
of interstitial flow could induce fibroblast motility as well as drive myofibroblast 
differentiation and matrix alignment [106]. Hence, fibroblasts appear to be highly 
sensitive to interstitial flow and heightened flow could drive myofibroblast differ-
entiation and extracellular matrix remodeling that recapitulates certain patho-
logical features of cirrhosis [107]. Besides, in cases of endotoxemia, this increased 
interstitial flow would collaborate in the production of edema in the space of 
Disse. In addition, endotoxemia favors the intrahepatic lymph stasis, which may 
be caused by a reduction in the pumping activity of the extra-hepatic and the 
intrahepatic large lymph vessels [108]. In turn, the edematous interstitial space of 
Disse could show analogies to typical stem cell niches to retain mesenchymal stem 
cells or stem-like cells as well as to influence their cellular fate [109]. In this sense, 
the edematous space of Disse could serve as a niche of the hepatic stellate cells 
because of their mesodermal origin [109].
7.  The reexpression of the trophoblastic-yolk sac-related phenotype in 
portal hypertension
An array of functions made up by the secondary yolk sac seems to be expressed 
by the organism when it suffers portal hypertension. In rats with prehepatic portal 
hypertension, the reexpression of this extra-embryonic phenotype by the splanchnic 
tissues and organs is coupled with the upregulation of the immune cells [2, 110, 111], 
as well as with the development of dyslipidemia and hepatic steatosis [112, 113]. 
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Prehepatic portal hypertension is one factor determining bacterial intestinal trans-
location to mesenteric lymph nodes [111, 114]. In addition, the increased presence 
of mast cells in the hypertrophied mesenteric lymph nodes [115] would not only col-
laborate in the production of mesenteric adenitis [111], but also would constitute a 
source of inflammatory mediators located between the intestine and systemic blood 
circulation [116]. The mesenteric lymph nodes are key structures involved in the 
gut-associated lymphoid tissue (GALT) [117]. GALT constitutes the largest lymphoid 
organ of the body, and its activation in portal hypertensive enteropathy results in the 
release of several inflammatory mediators. These mediators would be transported by 
the intestinal lymph nodes to the pulmonary circulation inducing an inflammatory 
phenotype and later to the systemic circulation [91, 118, 119].
In response to bacterial translocation, gut epithelial cells release chemokines that 
induce the recruitment of dendritic cells to the mucosae [100, 114]. Once activated, 
mature intestinal dendritic cells can induce and prime mucosal and mesenteric 
lymph nodes, B and T cells [100, 114]. After maturation, these B and T cells are 
released into the blood stream and, due to surface expression of the specific homing 
markers, home back to reside within the lamina propria [114]. In addition, aberrant 
intestinal T lymphocytes homing to the liver may contribute to trigger immune 
hepatic damage [100]. Moreover, data from the literature indicate a relationship 
between the gut microbiota and the intestinal stem cells. Thus, lipopolysaccharide-
sensitive cell types can be seen within bone marrow-derived cells which are 
involved in the development of inflammation in the adipose tissue of obese and 
type 2-diabetic mice [120]. Intestinal epithelial cells not only produce and release 
mediators affecting immune cells, but they also respond to factors produced by the 
subjacent immune cells [121]. In addition to the damage of intestinal epithelial cells, 
intestinal epithelial barrier dysfunction can result from loss of junctional complex 
integrity with increased paracellular permeability [100].
Nowadays, there have been various reports suggesting the role of gut flora and 
bacterial translocation in the pathogenesis of portal hypertension and chronic 
liver disease [101, 102, 122]. Translocated bacterial products could activate Kupffer 
cells through pattern recognition receptors such as toll-like receptors (TLRs) and 
NOD-like receptors (NLRs). Recent studies suggested that TLR4 signaling can be 
activated not only by pathogen-associated molecular patterns (PAMPs), but also 
by some endogenous ligands or damage-associated molecular patterns (DAMPs), 
which are released from damaged cells [123, 124]. In turn, activated Kupffer cells 
significantly increase their release of oxidative and nitrosative stress species and 
proinflammatory cytokines, including chemokines [101].
Chemokine expression by Kupffer cells, hepatic stellate cells, and sinusoidal 
endothelial cells drive the migration of immune cells populations [125]. In par-
ticular, CXCL12 (SDF-1α), which binds to the CXCR4 receptor, regulates several 
pathological responses. CXCL12 is crucial in early embryogenesis, hematopoiesis, 
and angiogenesis, as well as maintenance of the bone marrow stem cell niche 
[125]. In addition, the liver with its dual arterial and venous blood supply has a 
low oxygen tension, which has worsened during portal hypertension leading to 
hypoxic environment that could stimulate CXCL12 production with recruitment of 
immune cells [125].
Hepatic macrophages hold a central position in the pathogenesis of chronic liver 
injury. Resident hepatic macrophages or self-renewing embryo-derived local mac-
rophages, i.e., Kupffer cells, appear essential for initiating inflammatory response 
while infiltrating bone marrow-derived macrophages originated from circulating 
monocytes are linked to chronic inflammation and fibrogénesis [126]. However, 
after local differentiation into resident macrophages they could restore liver integ-
rity and then are termed restorative macrophages [126].
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In the yolk sac, the blood islands are generated by mesodermal cell aggregates 
that differentiate into both hematopoietic and endothelial cells [127]. The simulta-
neous appearance of these two lineages suggests the existence of a common ances-
tral precursor for endothelial and hematopoietic cells: the hemangioblast [128]. In 
addition, the embryo could generate their definitive hematopoiesis from a hemo-
genic endothelium derived from a transient mesenchymal population [126, 127]. 
This close physiological ontogenic association between hematopoiesis and angio-
genesis could persist during the pathophysiological response that produces portal 
hypertension. In this case, during the evolution of portal hypertensive pathology, 
the gut-liver axis could recapitulate the functions derived from the mesenchymal-
angiogenic-hematopoietic axis that form the blood islands in the yolk sac [125, 127].
It has been suggested that mast cells could mediate the pathogenic relation-
ship between portal hypertension and the angiogenic hyperactivity that occurs in 
experimental portal hypertension, particularly in the alimentary tract [110, 115]. 
The formation of new blood vessels is a key mechanism in the pathogenesis of por-
tal hypertension [129]. Although the precise mechanisms by which the angiogene-
sis-associated response in portal hypertension is modulated remain to be defined, 
several mediators produced by mast cells are involved in angiogenesis [110]. This 
is the reason why it has been proposed that the angiogenic hyperactivity occur-
ring in portal hypertension could mainly be mediated by mast cells [110, 115]. In 
addition, the exceeding angiogenesis through the neoformed collateral circulation 
allows portal blood flow to directly reach the systemic circulation [79]. However, 
the morphological vascular alterations stand out in the chronic portal hypertensive 
enteropathy [130]. The exacerbated angiogenesis produced in the intestinal wall 
during the evolution of portal hypertension is similar to the process of vasculo-
genesis that occurs in the extra-embryonic membranes [131]. More explicitly, the 
endothelial cells of the blood islands expand to cover the entire yolk sac creating a 
vascular network known as the capillary plexus [131], the precursor of the vitelline 
veins which, in turn, are the embryonic origin of the portal system [80].
From an ontogenic point of view, vitellogenesis plays a vital role in providing lipids 
and lipid-soluble nutrients to embryos [132]. The ability to transport fat in the form of 
lipoproteins through the circulatory system by eukaryotes is one of the most significant 
functions right from the beginning of existence [133]. Thus, the evolutionary advance-
ment of storing energy in the form of fat has provided organisms with enormous 
advantages for adapting to environmental and developmental changes [134].
We have previously shown that prehepatic portal hypertension in the rat induces 
liver steatosis and causes changes in lipid and carbohydrate metabolisms similar to 
those produced in chronic inflammatory conditions described in metabolic syn-
drome in humans [112, 113, 135]. It has been suggested that in experimental pre-
hepatic portal hypertension, the liver could constitute a kind of yolk sac in which 
the animal carries out a pathological deposit of lipids [81, 92]. Prehepatic portal 
hypertension in the rat, both in short- (1 month) and in the long-term (1 year), pro-
duces hepatic accumulation of triglycerides and cholesterol [112, 113]. Nonetheless, 
the mechanisms by which portal hypertension could induce liver steatosis are not 
finally understood [135] (Figure 4).
Inflammation, and the concomitant acute-phase response, induces marked 
changes in the lipoprotein profile [136]. Thus, in the prehepatic portal hypertensive 
rat, liver steatosis is associated with the plasmatic increase of low density lipopro-
tein (LDL) and lipopolysaccharide binding protein (LBP) as well as a reduction of 
high-density lipoproteins (HDL) [135]. In turn, hepatic steatosis might play a key 
role in the pathogenesis of cardiovascular disease through the systemic release of 
several inflammatory mediators and/or through the production of insulin resistance 
and atherogenic dyslipidemia [137, 138].
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Gut microbiota could alter nutrient absorption, energy homeostasis, and intes-
tinal permeability, with a translocation of bacteria-derived products to the liver. It 
could also cause hepatocellular inflammation and nonalcoholic fatty liver disease 
(NAFLD) [105, 139]. Western diet seems to cause dysbiosis, i.e., vitellogenic micro-
biome, which affects host gastrointestinal metabolism and contributes to higher 
incidences of metabolic syndrome, including NAFLD [139, 140]. Genetics might 
also modulate the spectrum of liver disease and its progression [141]. In turn, when 
portal hypertension coexists, the factors previously mentioned would represent an 
associated risk factor for the development of NAFLD and metabolic syndrome.
In portal hypertension, cholesterol synthesis could play a key role during the 
hypothesized reexpression of the vitellogenic phenotype. The liver plays a central 
role in cholesterol metabolism. Hepatocytes not only express a number of different 
lipoprotein receptors that enable them to take up cholesterol, but also synthesized 
cholesterol de novo within the liver [142, 143]. In addition, to these input pathways, 
the liver secretes cholesterol by two routes, the first, within triglyceride-rich very 
low density lipoprotein (VLDL) to supplying peripheral cells with fatty acids, fat 
soluble vitamins, and cholesterol. And, secondly, the liver releases cholesterol into 
bile, either directly as free cholesterol or after conversion into bile acids [142].
Cholesterol is used locally to synthesize glucocorticoids and mineralocorticoids, 
which could regulate microcirculatory functions and immune cell activation [144]. 
Perhaps, the ability of local corticosteroid synthesis is upregulated in the inflamed 
tissue due to the metabolic and functional needs of the neoformed tissue includ-
ing angiogenesis in portal hypertension [7, 22]. Moreover, the pro-inflammatory 
Figure 4. 
Histopathological images of rat liver with long-term portal hypertension (3 months). The liver presents 
diffuse steatosis (superior) and portal fibrosis (inferior) as the result of splanchnic and systemic inflammatory 
responses. This inflammatory process could be proposed as the representation of the recapitulated extra-
embryonic functions in the splanchnic area when portal hypertension is developed.
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and anti-inflammatory functions of androgens and estrogens and progesterone, 
respectively, suggest that endogenous sex steroids may influence immune func-
tions [145–147] and, therefore, the evolution of the portal inflammatory response. 
In particular, estrogen has been shown to be effective in animal models of portal 
hypertension with cirrhosis by suppressing hepatic fibrosis and relaxing the hepatic 
sinusoid, and could reverse the severity of hyperdynamic circulation and the vas-
cular hyporeactivity of the mesenteric arteries in portal hypertensive rats without 
cirrhosis [148].
Hence, it could be proposed that within the splanchnic impairments related 
to portal hypertension, the stimulation of the angiogenic-hematopoietic axis, 
the cellular and bacterial interstitial infiltration of the tissues and organs and the 
acute-phase-response, including dyslipidemia and hepatic steatosis (vitellogenic 
phenotype), seem to recall the functions characteristic of the secondary yolk sac 
during embryo development.
In this sense, the microvesicles, released from practically all cells including 
mesenchymal stem cells [149], would collaborate in inducing the recapitula-
tion of extra-embryonic functions during the evolution of portal hypertension. 
Microvesicles contain lipids, proteins, RNA, and micro-RNAs and could act as 
vectors of information that regulate the function of target cells [150]. Microvesicles 
from inflammatory cells are suspected to be involved in various diseases. In particu-
lar, microvesicles probably enhance portal hypertension by contributing to splanch-
nic vasomotor alterations and angiogenesis [151].
8.  Coupling extra-embryonic phenotypes to induce a gastrulation-like 
liver phenotype
In the current review, we propose that during the evolution of portal hyperten-
sion different extra-embryonic functions, such as the coelomic-amniotic and the 
trophoblastic-yolk sac or vitelline function, would be successively recapitulated. 
If so, the inflammatory conditions that characterize portal hypertension could 
actually represent the reexpression of extra-embryonic mechanisms that have been 
already used during the early phases of embryonic development. In this way, the 
pathophysiological mechanisms involved in the above-mentioned inflammatory 
response could represent the recapitulation of the extra-embryonic functions, 
which collaborate together to make an embryo-like tissue from gastrulation [7, 54] 
(Figure 3).
The liver stands out among other organs since its persistent injury usually results 
in the chronic activation of inflammation and the wound-healing response [7, 152]. 
Development of the liver during early embryogenesis may share similarities with 
pathophysiological processes seen in adulthood, such as acute liver injury and liver 
regeneration, but also in liver fibrosis [152–154]. The increasing knowledge of the 
extra-hepatic involvement typical of this fibrotic liver disease, however, suggests 
that this wound healing process is associated with a complex systemic pathogenesis 
[155]. Portal hypertension is the major hemodynamic complication of a variety of 
diseases that obstruct portal blood flow, including liver cirrhosis [79]. Portal hyper-
tension in the cirrhotic patient could be associated with hyperkinetic syndrome, 
increased total blood volume by sodium and water retention [155], endothelial 
dysfunction [81, 83, 156] in the splanchnic and systemic circulation [81, 83, 119], 
esophageal varices, ascites, encephalopathy, and hepatorenal syndrome [157].
The severe systemic complications of the portal hypertension syndrome 
accompanying the wound-healing liver reaction could be based on some metabolic 
similarities that can be established with the extra-embryonic coelomic-amniotic 
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Figure 5. 
Schematic representation of the systemic inflammatory response in portal hypertension in order to produce 
a systemic wound-healing phenotype. By means of two inflammatory phenotypes expression; i.e., neurogenic 
(CNS and AG) and immune (BMA), into the interstitial injured splanchnic area, an endocrine phenotype 
could be induced, that ultimately would causes a wound-like response. Thus, fibrosis and angiogenesis will be 
produced in the splanchnic area. A: angiogenesis; AG: adrenal gland; B: bile; BMA: bone marrow; BP: biliary 
proliferation; CHS: cholestasis; CNS: central nervous system; E: enterocyte; ES: endothelial sinusoid; G: goblet 
cell; HSC: hepatic stellate cell; IC: Ito cell; KC: Kupffer cell; Le: leukocyte; Mo: macrophages; M: myofibroblast; 
Mi: microbiome; SC: stem cells; SD: space of Disse.
and trophoblastic-yolk sac functions playing the leading role during embryonic 
development [7]. Thus, the confluence of these two extra-embryonic axes in the 
injured liver could favor a gastrulation-like response in which fibrogenesis could 
predominate [7, 22, 54]. Therefore, the wound-healing liver reaction that charac-
terizes the cirrhotic process could have properties comparable to an embryo and, 
in particular, with its initial evolutive phase, namely gastrulation [22]. If so, the 
gastrulation-related process with neoformation of a reparative tissue could be based 
on the recapitulation of the developmental process of the intra-embryonic mesen-
chyme [158].
The interstitial space of Disse could be schematically represented like an area 
fundamentally surrounded by a sinusoidal endothelium. Inside this endothelium, 
an inflammatory response is developed, which is made up by the hepatic stellate 
cell. In turn, the liver interstitial inflammation would be activated by means of the 
reexpression of extra-embryonic functions by the host organism, which provides 
molecules and cells selectively to the inflamed interstitial space through the sinusoi-
dal endothelium [22] (Figures 3 and 5).
Hepatic stellate cells are liver-specific mesenchymal cells located in the space 
of Disse between the sinusoidal endothelial cells and hepatic epithelial cells 
[159]. Hepatic stellate cells also known as Ito cells, fat-storing cells, vitamin 
A-storing cells, or lipocytes, store excess vitamin A as retinyl esters in lipid drop-
lets within their cytoplasm [159, 160]. In pathological conditions, hepatic stellate 
cells upon activation lose the vitamin A-containing lipid droplets and produce 
large amounts of collagen [160]. Therefore, modulation of vitamin A-containing 
lipid droplets has been suggested to have a therapeutic impact on the develop-
ment of liver fibrosis [160] (Table 2). Hepatic stellate cells are known to express 
both mesenchymal and neural lineage markers [161, 162]. Moreover, during 
17
The Wound-Healing Portal Hypertensive Response
DOI: http://dx.doi.org/10.5772/intechopen.84689
liver injury, stellate cells activate into alpha smooth muscle actin-expressing 
contractile myofibroblasts, which increase vascular resistance thereby promot-
ing portal hypertension [163, 164]. Mesodermal mesenchymal cells including 
hepatic stellate cells are the major source of myofibroblasts [164]. In this sense, 
activated-hepatic stellate cells also strengthen the immune response through the 
production of a wide array of cytokines and chemokines [4]. Finally, hepatic stel-
late cells are able to adopt a fibrogenic phenotype and participate in extracellular 
matrix remodeling [163] (Figure 4).
Kupffer cells activate hepatic stellate cells via paracrine mechanisms, likely 
involving the profibrotic and mitogenic cytokines TGF-β and PDGF [165, 166]. 
Early deposition of an extracellular matrix in the subendothelial space of Disse 
causes capillarization of the sinusoid, diminished liver function, and contributes 
to the perpetuation of hepatic stellate cell activation [159, 160, 167]. Liver fibro-
genesis is not only sustained by a heterogenic population of profibrogenic hepatic 
myofibroblasts [3, 4], but also includes mesothelial-related capsular fibrosis [167]. 
Mesothelial cells have a phenotype intermediate between epithelial cells and 
mesenchymal cells and these both type of cells could then undergo myofibroblastic 
transdifferentiation. Upon liver injury, it has been demonstrated that mesothe-
lial cells participate in capsular fibrosis of the liver surface via differentiation to 
hepatic stellate cells and myofibroblasts [167]. In portal hypertension, the forma-
tion of a fibrotic scar tissue in the liver is associated with the development of an 
excessive gastrointestinal angiogenic response [110]. Therefore, the two principal 
components for creating granulation tissue, i.e., fibroplasia and angiogenesis, are 
The coelomic-amniotic phenotype
• Hyperkinetic syndrome
• Stimulation of the hypothalamo-pituitary-adrenal axis and the sympathetic nervous system
• Interstitial splanchnic edema
• Increased mesenteric lymph circulation
• Ascitic fluid
The trophoblastic-yolk sac (vitelline) phenotype
• Acute-phase response
• Dyslipidemia
• Local metabolism of cholesterol (steroid hormones)
• Hepatic steatosis
• Recapitulated mesenchymal-angiogenic-hematopoietic axis
• Portal hypertensive enteropathy
• Dysbiosis and intestinal bacterial translocation
• Splanchnic microvesicles
The gastrulation-like phenotype
• Hepatic stellate cell activation
• Fat-storing cells
• Myofibroblast
• Hepatic fibrosis
Table 2. 
Portal hypertensive inflammatory phenotypes.
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distributed along the portal axis. In essence, the portal venous system continues 
playing a key role as a spatial delivery of functions in pathological situations.
9. Conclusion
The diverse functions of hepatic stellate cells in homeostasis and inflammation 
indicate the versatile nature of these mesenchymal-derived cells, which could adopt 
numerous phenotypes according to the interstitial microenvironmental character-
istics [163]. Therefore, these hepatic cellular population, thanks to their potential 
ability to integrate and reexpress functions showing analogies to extra-embryonic 
functions, display characteristics of stem/progenitor cells [109]. In this way, during 
the development of portal hypertension, hepatic stellate cells not only could reex-
press extra-embryonic functions but also could adapt themselves in order to induce 
a gastrulation-related process in the space of Disse. Therefore, by understanding 
the ontogenic interactions between hepatic stellate cells and the host inflammatory 
response in portal hypertension, it is possible to design effective therapeutic and 
prophylactic strategies to avoid or reverse wound-like hypertensive response.
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